Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma.
Yang QF, Sakurai T, Yoshimura G, Shan L, Suzuma T, Tamaki T, Umemura T, Kokawa Y, Nakamura Y, Nakamura M, Tang W, Utsunomiya H, Mori I, Kakudo K.
Yang QF, et al. Among authors: yoshimura g.
Breast Cancer Res Treat. 2000 Jun;61(3):211-6. doi: 10.1023/a:1006474307180.
Breast Cancer Res Treat. 2000.
PMID: 10965997